Spatial Transcriptomics in Neurodegeneration

Introduction

Spatial Transcriptomics In Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Spatial transcriptomics encompasses a family of technologies that measure gene expression [@chen2022] while preserving the spatial location of cells within intact tissue sections. Unlike dissociative single-cell approaches ([single-cell-genomics](/technologies/single-cell-genomics), spatial transcriptomics retains the tissue architecture, cellular neighborhoods, and microenvironmental context that are critical for understanding neurodegenerative — where pathology is inherently spatial, with amyloid plaques, tau] tangles], [alpha-synuclein](/proteins/alpha-synuclein), and reactive glia forming complex spatial relationships with vulnerable [neurons](/entities/neurons) ([Visualization et al., 2016](https://doi.org/10.1126/science.aaf2403)). [@stickels2021]

Introduction

Spatial Transcriptomics In Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Spatial transcriptomics encompasses a family of technologies that measure gene expression [@chen2022] while preserving the spatial location of cells within intact tissue sections. Unlike dissociative single-cell approaches ([single-cell-genomics](/technologies/single-cell-genomics), spatial transcriptomics retains the tissue architecture, cellular neighborhoods, and microenvironmental context that are critical for understanding neurodegenerative — where pathology is inherently spatial, with amyloid plaques, tau] tangles], [alpha-synuclein](/proteins/alpha-synuclein), and reactive glia forming complex spatial relationships with vulnerable [neurons](/entities/neurons) ([Visualization et al., 2016](https://doi.org/10.1126/science.aaf2403)). [@stickels2021]

Since its recognition as Nature's Method of the Year in 2020, spatial transcriptomics has rapidly matured from proof-of-concept experiments to large-scale brain [@zhang2023] mapping studies. Technologies now span the resolution-throughput spectrum from whole-transcriptome profiling with ~55 mum resolution (10x Visium to single-molecule detection at subcellular resolution (MERFISH, seqFISH+, Stereo-seq), enabling researchers to map disease pathology at unprecedented molecular detail ([Ståhl et al., 2016](https://doi.org/10.1126/science.aaf2403)) ([Highly et al., 2021](https://doi.org/10.1038). [@chen2022]

Core Technologies

Sequencing-Based Approaches

10x Visium and Visium HD: The most widely adopted spatial transcriptomics platform uses barcoded oligonucleotide arrays printed on glass slides. Tissue sections are placed on the array, permeabilized, and mRNAs hybridize to spatially barcoded capture probes. After reverse transcription and sequencing, transcripts are mapped back to their spatial locations. Standard Visium captures ~5,000 genes per 55 μm spot (each containing ~1-10 cells), while Visium HD achieves 2 μm resolution approaching single-cell level ([Spatial et al., 2020](https://doi.org/10.1016/j.cell.2020.06.038)). [@zhang2023]

Slide-seq and Slide-seqV2: Uses randomly barcoded 10 μm beads arranged on a glass surface, achieving near-cellular resolution with whole-transcriptome capture. Slide-seqV2 improved sensitivity ~10-fold over the original protocol, detecting ~2,500 genes per bead ([Stickels et al., 2021](https://doi.org/10.1038). [@chen2020]

Stereo-seq (STOmics): A nanoscale platform developed by BGI that achieves 500 nm resolution using DNA nanoball arrays, enabling subcellular spatial transcriptomics. Stereo-seq has been used to create high-resolution spatial maps of mouse and human brain tissue, including mapping microglial activation patterns in alzheimers ([Chen et al., 2022](https://doi.org/10.1016/j.cell.2022.04.003)) ([Spatiotemporal et al., 2022](https://doi.org/10.1016/j.cell.2022.04.003)). [@zeng2023]

Imaging-Based Approaches

MERFISH (Multiplexed Error-Robust Fluorescence In Situ Hybridization): Developed by Xiaowei Zhuang, MERFISH uses combinatorial barcoding and sequential rounds of hybridization, imaging, and probe removal to detect hundreds to thousands of RNA species at single-molecule resolution within intact cells. The Allen Institute has used MERFISH to create comprehensive spatial cell atlases of the mouse brain, detecting ~500 genes across millions of cells ([Zhang et al., 2023](https://doi.org/10.1038) ([Molecularly et al., 2023](https://doi.org/10.1038). [@kleshchevnikov2022]

seqFISH+ and seqFISH: Uses sequential rounds of fluorescent barcoding to detect up to 10,000 genes at single-molecule resolution, providing comprehensive spatial transcriptomic coverage comparable to scRNA-seq but with spatial information preserved. [@lewis2021]

STARmap and STARmap PLUS: Amplicon-based in situ sequencing methods that detect hundreds of genes simultaneously in thick tissue sections (up to 150 μm), enabling 3D spatial mapping of gene expression ([Nature et al., 2021](https://doi.org/10.1038). [@moffitt2018]

In Situ Sequencing (ISS): Padlock probes and rolling circle amplification generate bright fluorescent puncta that are sequenced in situ by sequential fluorescent imaging, providing targeted spatial gene expression at single-molecule resolution. [@cang2023]

Comparison of Platforms

| Platform | Resolution | Gene Panel | Throughput | Best Application | [@parkinsons]
|----------|-----------|------------|------------|------------------| [@michael]
| 10x Visium | ~55 μm | Whole transcriptome | High | Discovery, screening | [@national]
| Visium HD | 2 μm | Whole transcriptome | Moderate | Near-single-cell whole-transcriptome |
| Slide-seqV2 | 10 μm | Whole transcriptome | Moderate | High-resolution brain mapping |
| Stereo-seq | 500 nm | Whole transcriptome | High | Subcellular spatial analysis |
| MERFISH | 100 nm | 100-1,000 genes | Moderate | Single-cell/molecule resolution |
| seqFISH+ | 100 nm | Up to 10,000 genes | Low | Comprehensive single-cell spatial |

Applications in Neurodegenerative Disease Research

Alzheimer's Disease

Spatial transcriptomics has been particularly transformative for alzheimers research:

Plaque-associated transcriptional programs: Visium and MERFISH studies have mapped gene expression changes as a function of distance from [amyloid-beta](/proteins/amyloid-beta) plaques, revealing that plaque-proximal [microglia[://doi.org/10.1038/[s41593-020-00764-7[://doi.org/10.1038/[s41593-020-00764-7://doi.org/10.1038).

Microglial network mapping: A 2025 study using spatial transcriptomics mapped [microglial across the cortical landscape in alzheimers, revealing that [disease-associated [microglia](/cell-types/microglia-neuroinflammation) identify genes whose expression varies significantly across tissue space, revealing spatially patterned transcriptional programs that may be missed in dissociative scRNA-seq analyses.

Cell-Cell Communication Analysis

Spatial proximity information enables inference of cell-cell communication through ligand-receptor interaction analysis (COMMOT, stLearn, SpaTalk, NICHE-net), revealing which cell types communicate with each other in defined spatial microenvironments relevant to disease pathology.

Spatial Domain Identification

Unsupervised methods (BayesSpace, SpaGCN, STAGATE) identify transcriptionally coherent spatial domains — analogous to tissue regions or anatomical structures — enabling data-driven discovery of disease-associated spatial patterns.

Integration with Other Modalities

Multi-modal integration frameworks combine spatial transcriptomics with:

• Immunohistochemistry and immunofluorescence for protein co-detection
• amyloid PET and tau] PET imaging for correlation with clinical neuroimaging
• Whole-genome sequencing for genotype-spatial phenotype associations
• Electrophysiology for linking spatial molecular patterns to functional properties

Key Resources

Allen Brain Cell Atlas

The Allen Institute has generated a comprehensive MERFISH spatial transcriptomics dataset of the entire adult mouse brain, detecting ~500 genes across millions of cells with single-cell resolution. This atlas provides a reference framework for mapping cell types and states across the entire brain and has been widely adopted for neurodegenerative disease studies.

Human Brain Spatial Atlases

Multiple consortia (SEA-AD, Human Cell Atlas, BRAIN Initiative Cell Census) are generating spatial transcriptomic maps of the human brain across development, aging, and disease, creating reference resources for the neurodegeneration research community.

Challenges and Limitations

Technical Challenges

• Gene panel limitations: Imaging-based methods (MERFISH, seqFISH+) require pre-selection of gene panels, potentially missing unexpected disease-relevant transcripts
• Tissue quality: RNA degradation in postmortem human brain tissue affects signal quality, particularly for sequencing-based methods
• Throughput: Processing and imaging large tissue areas remains time-consuming, limiting the number of samples that can be analyzed
• 3D tissue mapping: Most methods work on thin (5-10 μm) tissue sections; capturing the full 3D spatial architecture requires serial section registration

Analytical Challenges

• Batch effects: Spatial artifacts from tissue processing, imaging, and sequencing can confound biological signal
• Statistical power: The spatial nature of data requires specialized statistical frameworks that account for spatial autocorrelation
• Multi-scale integration: Bridging subcellular, cellular, tissue, and organ-level spatial scales remains computationally challenging

Future Directions

Subcellular Spatial Resolution

Emerging methods combining expansion microscopy with spatial transcriptomics enable simultaneous visualization of subcellular RNA localization and organelle structure, potentially revealing how RNA mislocalization contributes to neurodegeneration.

Temporal-Spatial Mapping

Integration of spatial transcriptomics across disease progression time points will enable mapping of how pathological spatial patterns evolve over time — tracking the spread of tau] propagation], [prion-like spreading](/mechanisms/prion-like-spreading), and inflammatory zone expansion.

Clinical Applications

Spatial transcriptomics of cerebrospinal fluid cells and peripheral blood could provide spatially informed "liquid biopsies" for neurodegenerative disease diagnosis and monitoring, while spatial profiling of brain biopsy tissue could guide precision therapeutic decisions.

Whole-Brain Spatial Atlases

Large-scale efforts to map the entire human brain at single-cell spatial resolution across the lifespan and disease spectrum will provide definitive reference frameworks for understanding [neurodegeneration.

See Also

• [Microglia](/cell-types/microglia)
• [brain-organoids](/technologies/brain-organoids)
• [single-cell-genomics](/technologies/single-cell-genomics)

Background

The study of Spatial Transcriptomics In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

References